Provided by Tiger Trade Technology Pte. Ltd.

Invivyd, Inc.

1.38
-0.0700-4.83%
Post-market: 1.390.0100+0.72%19:34 EDT
Volume:6.70M
Turnover:9.31M
Market Cap:389.16M
PE:-4.53
High:1.48
Open:1.47
Low:1.37
Close:1.45
52wk High:3.07
52wk Low:0.4600
Shares:282.00M
Float Shares:204.00M
Volume Ratio:2.37
T/O Rate:3.28%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3048
EPS(LYR):-0.3048
ROE:-33.96%
ROA:-17.09%
PB:1.61
PE(LYR):-4.53

Loading ...

Invivyd Announces Pricing of $125 Million Public Offering of Common Stock and Pre-Funded Warrants

THOMSON REUTERS
·
Nov 18, 2025

Invivyd Inc - Prices Public Offering of 44 Mln Shares at $2.50 Each

THOMSON REUTERS
·
Nov 18, 2025

Invivyd Launches Public Stock Offering

MT Newswires Live
·
Nov 18, 2025

Invivyd announces common stock offering, no amount given

TIPRANKS
·
Nov 18, 2025

Invivyd Announces Proposed Public Offering of Common Stock

THOMSON REUTERS
·
Nov 18, 2025

Invivyd (IVVD): Assessing Valuation After Strong Q3 Results and FDA Progress on VYD2311

Simply Wall St.
·
Nov 15, 2025

Cantor Fitzgerald Keeps Their Buy Rating on Invivyd (IVVD)

TIPRANKS
·
Nov 07, 2025

Invivyd Q3 net loss beats estimates on higher PEMGARDA sales among healthcare providers

Reuters
·
Nov 06, 2025

Invivyd Q3 EPS USD -0.06

Reuters
·
Nov 06, 2025

Invivyd Inc. reports Q3 net product revenue of $13.1 million

Reuters
·
Nov 06, 2025

Invivyd Appoints Paul B. Bolno to Board and Kristie Kuhl as Chief Communications Officer

Reuters
·
Nov 06, 2025

Invivyd Q3 Revenue USD 13.129 Million

THOMSON REUTERS
·
Nov 06, 2025

Invivyd Inc expected to post a loss of 8 cents a share - Earnings Preview

Reuters
·
Nov 04, 2025

Invivyd Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Nov 03, 2025

Invivyd price target raised to $10 from $5 at H.C. Wainwright

TIPRANKS
·
Oct 31, 2025

Invivyd, Inc. : H.c. Wainwright Raises Target Price to $10 From $5

THOMSON REUTERS
·
Oct 31, 2025

Invivyd Inc. Hosts Webcast on REVOLUTION Clinical Program for COVID Prevention Antibody

Reuters
·
Oct 28, 2025

Invivyd Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Oct 07, 2025

Cantor Fitzgerald Initiates Invivyd at Overweight With $10 Price Target

MT Newswires Live
·
Oct 06, 2025

Invivyd Shares Climb After FDA Advances Its Covid-Preventing Drug

Dow Jones
·
Oct 06, 2025